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Summary
Langerhans cells (LCs) are prominent dendritic cells
(DCs) in epithelia, but their role in immunity is poorly
defined. To track and discriminate LCs from dermal
DCs in vivo, we developed knockin mice expressing
enhanced green fluorescent protein (EGFP) under the
control of the langerin (CD207) gene. By using vital
imaging, we showed that most EGFP+ LCs were ses-
sile under steady-state conditions, whereas skin in-
flammation induced LC motility and emigration to
lymph nodes (LNs). After skin immunization, dermal
DCs arrived in LNs first and colonized areas distinct
from slower migrating LCs. LCs reaching LNs under
steady-state or inflammatory conditions expressed
similar levels of costimulatory molecules. Langerin
and EGFP were also expressed on thymic DCs and
on blood-derived, CD8+ DCs from all secondary lym-
phoid organs. By using a similar knockin strategy in-
volving a diphtheria toxin receptor (DTR) fused to
EGFP, we demonstrated that LCs were dispensable*Correspondence: bernardm@ciml.univ-mrs.frfor triggering hapten-specific T cell effectors through
skin immunization.
Introduction
LCs are a subset of DCs that reside in their immature
state in epidermis and mucosal epithelia. LCs were
shown to be responsible for cutaneous graft-versus-
host disease in allogeneic bone marrow transplantation
settings (Merad et al., 2004). In contrast, by using
mouse models in which infection with herpes simplex
virus is confined to vaginal or epidermal epithelia, it has
been reported that non-LC-derived DCs are necessary
for in vivo generation of viral-specific effector T cells
(Allan et al., 2003; Belz et al., 2004; Iwasaki, 2003; Zhao
et al., 2003). However, these findings did not exclude
an indirect role of LCs in T cell priming, possibly in car-
rying-over antigens (Ags) to blood-derived DCs that re-
side permanently in cutaneous lymph nodes (CLNs)
(Carbone et al., 2004). A currently accepted paradigm
suggests that DCs are tolerogenic when they present
Ag under steady-state noninflammatory conditions. In
contrast, when stimulated by inflammatory mediators,
they mature and induce effector T cell responses
(Probst et al., 2003; Steinman and Nussenzweig, 2002).
In the presence of high numbers of Ag-specific T cells,
steady-state LCs appear, however, capable of pre-
senting self, keratinocyte-expressed Ag to naive T cells
in an immunogenic fashion (Mayerova et al., 2004). The
role played by LCs remains thus controversial.
At least five mouse CD11c+ DC subsets have been
identified (Asselin-Paturel et al., 2003; Dakic et al.,
2004; Henri et al., 2001; Itano and Jenkins, 2003; Ruedl
et al., 2000; Wilson et al., 2003). Three are found in all
secondary lymphoid organs, including the spleen. Be-
cause the spleen lacks afferent lymphatic vessels, the
precursors of these DC subsets likely reached lym-
phoid organs from the blood. These blood-derived DC
subsets have an immature phenotype, characterized by
low levels of MHC class II (MHCII) and costimulatory
molecules, and can be subdivided into CD11b+ DCs,
CD8α+ DCs, and plasmacytoid DCs. The two remaining
DC subsets are found in CLNs and appear to derive
from LCs and dermal DCs. Cells similar to the dermal
DC-derived population are also found in LNs that do
not drain skin territories, such as mesenteric lymph
nodes (MLNs), and likely represent the progeny of inter-
stitial DCs found in the parenchyma of nonlymphoid
tissues. The two subsets of skin-derived DCs found in
CLNs express a mature phenotype, characterized
by high levels of MHCII and costimulatory molecules.
The cell-surface markers used to discriminate LCs
from dermal DCs display continuous density distribu-
tions. For instance, LCs are CD11blow to high and
CD205inter to high, whereas interstitial and dermal DCs
are CD11bhigh and CD205low to inter. Therefore, even
when several markers are combined, the unambiguous
identification of LCs and dermal DCs is hampered by
their overlapping phenotypes (Itano et al., 2003; Wilson
et al., 2003).
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nexpressed on the surface of LCs and in LC-specific in-
tracellular organelles known as Birbeck granules (Valla- (
Edeau et al., 2000). Disruption of the langerin gene pre-
vents Birbeck granule formation without detectably E
daffecting LC function (Kissenpfennig et al., 2005). To
track LCs in vivo, we engineered knockin mice that ex- b
tpress an EGFP under the control of the langerin gene.
These mice are ideally suited to monitor the dynamics l
wof EGFP+ LCs in the epidermis under steady-state or
inflammatory conditions without having to label them d
tin vitro, a procedure known to alter their in vivo beha-
vior (Lindquist et al., 2004). These mice also allowed
eus to discriminate EGFP+, LC-derived DCs, and EGFP−
dermal-derived DCs with regard to their kinetics of mi- t
dgration to and pattern of distribution within CLNs. In a
second knockin, where a human DTR fused to EGFP n
twas placed under the control of the langerin gene, we
conditionally eliminated LCs in vivo and showed that m
pthey are dispensable for skin contact hypersensitivity
(CHS). d
a
iResults
t
LGeneration of Langerin-EGFP and Langerin-
sDTREGFP Knockin Mice
tTwo distinct expression cassettes were introduced in
Ethe 3# untranslated region of the langerin (CD207) gene
1(see Supplemental Experimental Procedures available
oin the Supplemental Data with this article online). One
mconsisted of an internal ribosomal entry site (IRES) and
tof an EGFP. In a second cassette, the 5# end of the
3EGFP open reading frame was linked in frame to a hu-
man DTR cDNA. Expression of the DTR-EGFP fusion
protein should confer DT sensitivity to langerin-express- L
ing cells and permit monitoring of their ablation after T
DT administration (Jung et al., 2002). As depicted in o
Figure S1, the result of our knockin approach was lim- m
ited to the insertion within the 3# untranslated region of D
the langerin gene of an IRES-driven cassette and of a e
residual loxP site. Knockin mice with the intended in- m
sertion, called Lang-EGFP or Lang-DTREGFP mice, W
were born at the expected frequencies, and homozy- l
gous animals were healthy. 4
(
tEGFP Expression and Morphology of LCs
En face views of epidermal sheets from ear skin of 2
tLang-EGFP and Lang-DTREGFP mice revealed a regu-
lar network of EGFP+ cells with typical LC morphology r
v(Figure 1A). All LCs identified using langerin (Figure 1A)
or MHCII (data not shown) expression were EGFP+. w
SConversely, all the EGFP+ cells in epidermis corres-
ponded to LCs and expressed levels of langerin com- t
[parable to wild-type (wt) LCs, indicating that insertion
of the IRES-driven cassettes did not affect langerin t
agene expression (Figure 1A). Moreover, in both knock-
ins, the morphology (including the presence of Birbeck
sgranules) and density of LCs were similar to those of
wt littermates, indicating that expression of EGFP or m
tDTREGFP affected neither LC generation nor morphol-
ogy (Figures 1A and 1B and Figure S2). Skin-organ cul- S
ftures performed in the presence of the chemokine
CCL21 further indicated that EGFP and DTREGFP ex- tression did not prevent LC migration (see below). A
ormal distribution of dendritic epithelial T cells
DETCs) was also observed in the epidermis of Lang-
GFP mice (Figure 1C). In steady-state dermis of Lang-
GFP mice (Figure 1D), we observed MHCII+, EGFP−
ermal DCs and only rare MHCII+, EGFP+ cells, possi-
ly LC-derived DCs in transit to CLNs. Therefore, in
hese two knockins, dermal DCs do not express the
angerin-driven cassettes, a feature that is consistent
ith previous studies (Valladeau et al., 2000) and makes
ermal DCs from Lang-DTREGFP mice resistant to DT
reatment (see below).
3D confocal microscopy and image reconstruction of
ar epidermis explants from Lang-EGFP mice revealed
hat steady-state LCs displayed thin and branched
endrites closely intermingled with neighboring kerati-
ocytes (Figure S3A and 3D animation in Movie S1). To
rigger LC maturation and emigration from the epider-
is, we used tape stripping of the ear skin. This ap-
roach removes the stratum corneum and the hairs and
isrupts the permeability of the epithelial barrier (Tigel-
ar et al., 1982). The density of EGFP+ LCs detected
mmediately after tape stripping was comparable to
hat found in contralateral, untreated ear, indicating that
Cs were not extracted from the epidermis (data not
hown). To activate LCs, we preferred tape stripping
o UVB irradiation (Merad et al., 2002), which leads to
GFP bleaching and precludes subsequent imaging.
6–24 hr after applying such mechanical trauma to ears
f Lang-EGFP mice, LCs underwent morphological
odifications, showing rounded cell bodies and fewer
hicker and nonbranched dendrites (Figure S3D and
D animation in Movie S2).
C Motility after Skin Mechanical Trauma
o visualize the motion of LC cell bodies and dendrites
ver time, intravital confocal microscopy of ear epider-
is was performed on anaesthetized Lang-EGFP mice.
ue to reflection and to autofluorescence signals gen-
rated from the highly absorbing hairs and melanocytes,
ultiphoton confocal imaging was found inappropriate.
e therefore used confocal imaging, adopting a time-
apse imaging mode where skin LCs were imaged every
min for 60 min by using low laser light illumination
see Supplemental Experimental Procedures). To cap-
ure the details of LC dendrite motility, we performed a
D projection for each time-lapse 3D stack and overlaid
he 0 min, 30 min, and 60 min timepoints by using a
ed-green-blue (RGB) color code. This encoding re-
ealed that under steady-state conditions, most LCs
ere sessile over the 1 hr recording period (Figure
3B). Rare motile LCs were, however, observed over
his period (cells with split RGB colors in Figure S3B
arrow] and at time t32 min in Figure S3C). Video anima-
ions showing 15 consecutive RGB color-coded images
re provided in Movies S3–S5.
In contrast to the sessile LC behavior noted in
teady-state ear epidermis, tape stripping induced LC
otility after 24 hr in all the fields where mechanical
rauma and depilation occurred (Figure S3E and Movies
6–S9 and S12). Over the 60 min recording period, dif-
erent patterns of dendrite outgrowth occurred be-
ween the tightly packed keratinocyte bodies (Figure
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645Figure 1. Confocal Microscopic Analysis of Skin from Wild-Type, Lang-EGFP, and Lang-DTREGFP Mice
(A) Staining of fixed epidermal sheets from Lang-EGFP and Lang-DTREGFP mice with an anti-langerin monoclonal antibody (mAb) (red)
shows that all EGFP+ cells (green) express langerin. The last row shows an overlay of pictures in the first two rows. Genotypes are indicated
for each column and markers on the left. All panels correspond to a 206.8 × 206.8 × 10.4 m optical section.
(B) In contrast to the cytosolic EGFP fluorescence found in LCs from Lang-EGFP mice, LCs from Lang-DTREGFP mice show a pattern of
EGFP fluorescence mainly associated with membranes. Each panel corresponds to a 54.2 × 43.4 × 7.4 m optical section.
(C) Staining of fixed sections of adult ear from Lang-EGFP mice with anti-CD3 (red) shows EGFP+ epidermal LCs (green) interspersed with
dendritic epidermal T cells (red). Optical section volume: 325.8 × 156.0 × 7.2 m.
(D) Staining of fixed sections of adult ear from Lang-EGFP mice with anti-MHCII (red). Rare MHCII+, EGFP+ LC-derived DCs (marked with a
star) are found in the dermis, together with MHCII+, EGFP− dermal DCs (red). Optical section volume: 120.4 × 98.5 ×7.2 m.
Abbreviations: Ep, epidermis; D, dermis; dDC, dermal DCs.S3F) and corresponded to extension (red), retraction
(blue), or transient changes (green). LC migration was
documented by the disappearance of some LC bodies
during the 60 min recording (Figure S3E, arrow). Video
animations showed that all the LCs experienced den-
drite and/or cell body motility over 60 min (Movies S6–
S9). Analysis performed only 5 hr after tape stripping
indicated that most LC-cell bodies and dendrites were
sessile as in the control and that rare LCs located close
to hair follicles, or at the dermis-epidermis interface,
experienced some tethered motions (Movies S10 and
S11). Therefore, vital confocal imaging revealed a mas-
sive mobilization of LCs secondary to skin mechanical
trauma. The few LCs that manifest motile behavior in
the epidermis of mice kept under specific pathogen-
free conditions and not subjected to inflammatory stim-
uli likely contribute to the continuous LC replacement
that occurs in CLNs under steady-state conditions (Ka-
math et al., 2002; Merad et al., 2002).
EGFP+ DCs in Cutaneous LNs
Although langerin expression is downregulated upon
LC maturation, LCs still retain detectable levels of lang-erin once they reach CLNs (Stoitzner et al., 2003), and
EGFP+ DCs could be readily identified in sections of
steady-state CLNs from Lang-EGFP mice (Figure S4).
When CLN sections were stained with markers that de-
fine T and B cell zones, EGFP+ DCs were found in T
cell zones (Figure S4A) and were excluded from B cell
zones (Figure S4B). To examine whether EGFP+ DCs
primarily accumulated near high endothelial venules
(HEVs), CLN sections of Lang-EGFP mice were stained
with an antibody (Ab) specific for PNAd, a peripheral
LN addressin that is selectively found on the luminal
face of HEVs. As shown in Figure S4C, under steady-
state conditions, rather than being located near and
around HEVs, EGFP+ DCs were excluded from the peri-
HEV zone.
We further characterized the EGFP+ DCs present in
CLNs from Lang-EGFP mice by flow cytometry and
found that all the EGFP+ cells were included within the
CD11c+ fraction, representing 38% ± 11% of it (Figure
2A). Three main clusters of DCs were distinguished on
an MHCII-CD11c dot plot (Figure 2B, subcutaneous
LN). One cluster with a very strong expression of MHCII
and intermediate to high levels of CD11c (MHCIIhigh,
CD11cinter to high subset) represented 30% ± 8% of the
Immunity
646Figure 2. Phenotype of EGFP+ DCs Found in Subcutaneous LNs, MLNs, Spleen, and Thymus of Lang-EGFP Mice
(A) To enrich for DCs, CLNs were treated with collagenase and low-density fractions purified on NycoPrep gradient. After gating out autofluo-
rescent cells (mostly macrophages) by using the FL3 or FL6 channel (den Haan et al., 2000; Wilson et al., 2003), large cells (as defined using
FSC versus SSC profile) were analyzed for expression of EGFP and CD11c. Two subsets of CD11c+, EGFP+ DCs (denoted I and II) can
be distinguished.
(B) Dot plots on the left column (Total) show the expression of CD11c versus MHCII on nonautofluorescent, low-density large cells from the
indicated organs. Dot plots on the right column show the CD11c versus MHCII distribution on nonautofluorescent, low-density large cells
gated for the expression of EGFP (EGFP+). Windows corresponding to the MHCIIhigh, CD11cinter to high; MHCIIinter, CD11chigh; and MHCIIlow,
CD11cinter subsets are shown. The percentage indicated for each window corresponds to the percentage of cells among CD11c+ cells (left
column dot plots) or among EGFP+ cells (right column dot plots). The EGFP histograms corresponding to each of the DC subsets are shown
in Figure S5A.
(C) Surface expression of CD8α on the CD11cinter to high, EGFPbright (subset I in [A]) and CD11chigh, EGFPinter (subset II in [A]) DCs found in CLNs.
(D) The langerin protein is expressed in both the CD8α+ and the LC-derived DC subsets found in the CLNs of wt mice. DCs were analyzed
for expression of CD11c and CD8α, and the CD11c+, CD8α+ and CD11c+, CD8α- DC subsets gated as specified. Histograms show the
expression of intracellular langerin on CD11c+, CD8α+ (gray histogram) and CD11c+, CD8α− (white histogram) DCs. The dotted histogram
corresponds to an isotype-matched negative control.
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647CD11c+ fraction, corresponded to tissue-derived DCs,
and contained both dermal-derived DCs and LC-
derived DCs (Dakic et al., 2004). A second cluster with
intermediate levels of MHCII molecules and high levels
of CD11c (MHCIIinter, CD11chigh subset) represented
6.5% ± 2% of the CD11c+ fraction and contained
blood-derived CD8α+ DCs and CD11b+ DCs. Finally, a
third cluster with intermediate levels of CD11c and low
surface levels of MHCII included both blood-derived
CD11b+ DCs and plasmacytoid DCs. Based on previ-
ous studies of CLNs (Valladeau et al., 2002), we ex-
pected EGFP expression to be restricted to LC-derived
DCs. However, two well-segregated EGFP+ DC subsets
were distinguishable in CD11c-EGFP (Figure 2A),
MHCII-CD11c (Figure 2B), and CD8α-CD205 (Figure 3A)
dot plots. The main EGFP+ DC subset, representing
88% ± 5% of the EGFP+ fraction, showed a phenotype
(MHCIIhigh, CD11cinter to high, CD205high, CD8α−) match-
ing that expected for LC-derived DCs (Figures 2B, 2C,
and 3A). The second EGFP+ DC subset represented
8.5% ± 4% of the EGFP+ fraction and had an MHCIIinter,
CD11chigh, CD205inter, CD8α+ phenotype (Figures 2B,
2C, and 3A) that unequivocally identified it as theFigure 3. Kinetics of Appearance of TRITC-
Labeled DCs in Auricular LNs after Painting
Ear Skin from Lang-EGFP Mice with TRITC
and a Skin Irritant
(A) Total CD11c+ DCs and CD11c+, EGFP+
DCs found in CLNs from Lang-EGFP mice
were analyzed for the expression of CD8α
versus CD205. Two subsets of EGFP+ DCs
can be distinguished. The major one shows
a CD205high, CD8α− phenotype matching
that expected for LC-derived DCs, whereas
the minor one had a CD205inter, CD8α+
phenotype corresponding to that of blood-
derived CD8α+ DCs. The EGFP histograms
corresponding to each of the gated DC pop-
ulations are shown in Figure S5B.
(B) Phenotype of TRITC+ DCs found in drain-
ing auricular LNs 4 days after TRITC paint-
ing. DCs were prepared from pooled auricu-
lar LNs and stained with Ab to CD11c,
CD205, and CD8α. After gating on CD11c+
cells, two TRITC+ DC populations can be de-
fined on the basis of EGFP expression as
TRITC+, EGFP+ and TRITC+, EGFP−. The ex-
pression of CD8α versus CD205 on TRITC+,
EGFP+ DCs; TRITC+, EGFP− DCs; as well as
on TRITC−, EGFP+ DCs is shown. TRITC+,
EGFP+ DCs showed a CD205inter to high,
CD8α− phenotype expected for LC-derived
DCs, whereas TRITC+, EGFP− DCs showed a
CD205inter to low, CD8α− phenotype that cor-
responds to dermal-derived DCs. Impor-
tantly, all the blood-derived, CD8α+ DCs are
found among the TRITC−, EGFP+ DCs. This
last population also contains the LC-derived
DCs that have reached the auricular lymph
nodes prior to TRITC painting.
(C) Percentage of TRITC+ DCs found in
draining auricular LNs from 1–6 days after
TRITC painting. By using FACS, TRITC+ DCs
were segregated into EGFP+ LC-derived
DCs and EGFP− dermal-derived DCs. Re-
sults correspond to the mean of two inde-
pendent experiments.blood-derived, CD8α+ DC subset found in CLNs (An-juere et al., 1999; Dakic et al., 2004; Henri et al., 2001;
Itano et al., 2003; Wilson et al., 2003). Note that 36% ±
9% of the CD8α+, CD205inter DCs found in CLNs did not
express EGFP (Figure S5B, panel II).
The presence of this unexpected CD8α+, EGFP+ DC
subset may result from a knockin artifact leading to the
spurious expression of EGFP in DCs that do not nor-
mally express langerin. To address this point, DCs from
wt CLNs were permeabilized and stained for cytoplas-
mic langerin with a specific mAb. Langerin was clearly
found expressed in both the CD8α+ and the LC-derived
DC subset (Figure 2D). The levels of langerin and of
EGFP expressed by the two subsets differed, however.
The LC-derived DC subset expressed on average
higher levels of both langerin and EGFP than the CD8α+
DC subset (Figures 2A and 2D and Figure S5B). There-
fore, the pattern and levels of expression of EGFP in
LC-derived DCs and CD8α+ DCs of Lang-EGFP mice
genuinely reflected those of the langerin gene itself.
Langerin+ DCs in Mesenteric LNs, Spleen,
and Thymus
Langerin gene transcripts have been noted in spleen
and MLNs (Takahara et al., 2002; Valladeau et al., 2002)
Immunity
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mAb in a minor population of DCs (Stoitzner et al., 2003;
Valladeau et al., 2002). As neither spleen nor MLNs t
ldrain the skin, this suggested that the uncharacterized
population of langerin+ DCs they contained were unre- L
tlated to epidermal LCs or that a fraction of LC-derived
DCs had trafficking properties allowing it to access c
dsecondary lymphoid organs other than CLNs. As
previously described for wt mice (Itano et al., 2003;
(Wilson et al., 2003), tissue-derived DCs (MHCIIhigh,
CD11cinter to high) are absent from the spleen and pre- t
Lsent in reduced numbers in MLNs from Lang-EGFP
mice (Figure 2B). However, spleen and MLNs contained D
na minor EGFP+ DC subset representing 16% and 8%
of the CD11c+ fraction, respectively (Figure 2B). These i
tEGFP+ DCs expressed CD8α, and their CD11c versus
MHCII profile was indistinguishable from that typical of p
Ethe blood-derived CD8α+ DC subset (Figure 2B and
data not shown). Therefore, as inferred from the EGFP i
rreporter and as previously hinted in the case of the
spleen (McLellan et al., 2002), langerin expression is not c
tlimited to LCs in epidermis and LC-derived DCs in
CLNs. Langerin is also expressed on the majority of the d
eblood-derived, CD8α+ DCs found in all secondary lym-
phoid organs. n
TTwo EGFP+ DC subsets were present in the thymus,
representing together 44% of the CD11c+ fraction I
p(Figures 2B and Figure S6A). One had an MHCIIinter,
CD11chigh, CD205+, CD8α+ phenotype similar to that of C
sblood-derived CD8α+ DCs, whereas the other one had
an MHCIIhigh, CD11cinter to high, CD205+, CD8α+ pheno-
dtype that, if we except the expression of CD8α, resem-
bles that of LC-derived DCs found in CLNs (Figure 2B 3
Eand Figure S6A). Analysis of the state of maturity
of the EGFP+, MHCIIinter, CD11chigh and of the EGFP+, t
TMHCIIhigh, CD11cinter to high thymic DCs showed that
they expressed levels of MHCII, CD40, and CD86 mole- p
3cules similar to those of the EGFP+, CD8α+ and of the
EGFP+, CD8α− DCs found in CLNs, respectively (Fig- d
Cures S6B and S7A). Although the presence of thymic
DCs with a phenotype and state of maturation resem- d
Ebling those of the LC-derived DCs found in CLNs is
unexpected for a primary lymphoid organ, it is consis- d
Ttent with previous studies that revealed the presence
of Birbeck granules in uncharacterized interdigitating g
cells of the thymus (Hoefsmit et al., 1982). In the pro-
cess of backcrossing the 129/SV-derived Lang-EGFP M
mice onto C57BL/6 mice, the ratio of the two EGFP+ C
DC subsets found in the thymus changed, the subset W
resembling LC-derived DCs found in CLNs becoming E
more represented (compare Figure 2B [backcross 2] E
and Figure S6A [backcross 6]). Therefore, as previously p
demonstrated for plasmacytoid DCs (Asselin-Paturel et c
al., 2003), the representation of the two langerin-posi- m
tive DC subsets likely varies between mouse strains. t
i
Dermal DC Migration Precedes that of LCs
Dermal-derived (EGFP−) DCs and LC-derived (EGFP+) o
CDCs represented 44% ± 9.5% and 53% ± 11% of the
tissue-derived DCs (MHCIIhigh, CD11cinter to high) found o
3in CLNs, respectively (Figure S5A). In CLNs, LC-derived
DCs expressed on average higher levels of CD205 C
gthan dermal-derived DCs (Figure 3B, compare panels
TRITC+EGFP+ and TRITC+EGFP−). A similar distinctiveD205 expression was already found on LC- and der-
al-DC emigrants crawling out of ear skin explants in
he presence of CCL21 (Figure S7D). However, the over-
ap in CD205 distribution precludes discriminating
C- and dermal-derived DCs on that sole basis. In con-
rast, expression of EGFP in Lang-EGFP mice allowed a
lear discrimination of LC-derived (EGFP+) and dermal-
erived (EGFP−) DCs (Figure S5A, panel I).
After epicutaneous application of a fluorescent dye
TRITC) and of a skin irritant, the first TRITC-laden DCs
o reach the draining LN have been claimed to be either
C-derived DCs (Ruedl et al., 2000) or dermal-derived
Cs (Kamath et al., 2002). The possibility to discrimi-
ate LC immigrants (TRITC+, EGFP+) from dermal DC
mmigrants (TRITC+, EGFP−) allowed us to reevaluate
his issue. CD11c+ DCs from draining CLNs of TRITC-
ainted Lang-EGFP mice were examined by FACS for
GFP and TRITC expression (Figure 3B). TRITC-carry-
ng DCs appeared in CLNs one day after skin painting,
eached a plateau at days 2–4, and subsequently de-
lined (Figure 3C). This kinetics and the absence of de-
ectable TRITC in the CLN subcapsular sinus and con-
uits at early (3 hr) and late (1–4 days) time points after
picutaneous application of TRITC (Figure 4 and data
ot shown) suggest that the labeled DCs have acquired
RITC in the skin (Gretz et al., 2000; Itano et al., 2003).
n support of that view, TRITC was absent at all time-
oints from nonskin-derived DC subsets found in
LNs, including the EGFP+, CD205inter, CD8α+ DC sub-
et (Figure 3B and data not shown).
The DCs that carry TRITC to the auricular LNs were
etected in both EGFP+ and EGFP− fractions (Figure
B). By using CD8α versus CD205 staining, the TRITC+
GFP+ fraction showed the CD205high, CD8α− pheno-
ype expected for LC-derived DCs, whereas the
RITC+, EGFP− fraction showed the CD205inter, CD8α−
henotype expected for dermal-derived DCs (Figure
B). Substantial numbers of immigrating, dermal-
erived DCs (TRITC+, EGFP−) were found in draining
LN as early as 24 hr after skin painting and peaked at
ay 2, whereas immigrating, LC-derived DCs (TRITC+,
GFP+) reached draining CLN more slowly, peaking 4
ays after skin painting (Figure 3C). Therefore, after
RITC-painting and skin inflammation, dermal DC mi-
ration clearly preceded LC migration.
ature Phenotype of LCs in Steady-State
utaneous LNs
e analyzed next the state of maturity of the two
GFP+ subsets found in CLNs. When compared to
GFP+, CD8α+ DCs, the EGFP+, LC-derived DCs ex-
ressed higher levels of MHCII, CD40, and CD86 at the
ell surface, a phenotype matching that expected for
ature DCs (Figure S7A). In contrast, EGFP+ LCs from
rypsinized epidermis showed a surface phenotype typ-
cal of immature DCs (Figure S7C).
After epicutaneous application of TRITC on ear skin
f Lang-EGFP mice, LC-derived DCs that reached
LNs under inflammatory conditions can be identified
n the basis of their TRITC+, EGFP+ phenotype (Figure
B). When compared to LC-derived DCs that reached
LNs under steady-state conditions, they were indistin-
uishable in terms of CD80, CD86, CD40, and MHCIIsurface expression (Figure S7B). Therefore, consistent
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649Figure 4. After Skin Inflammation, Dermal-
Derived and LC-Derived DCs Colonize Dis-
tinct Areas of the Paracortex of Draining
CLNs
Sections of auricular LNs from Lang-EGFP
mice were stained with the indicated anti-
bodies 24, 72, and 96 hr after painting ear
skin with TRITC and a skin irritant. In all of
the panels, LC-derived DCs that had
reached the draining auricular LNs prior to
TRITC application are colored in green. In-
coming EGFP+ LC-derived DCs (green) that
had captured TRITC (red) in the epidermis
had yellow-colored cell bodies, whereas the
EGFP− dermal-derived DCs that had cap-
tured TRITC in the dermis appeared as red
cells. Note that EGFP+, CD8α+ DCs repre-
sent w15% of the EGFP+ cells (see Figure
2B) and cannot be discriminated from the
major EGFP+ LC-derived DC subset based
on EGFP immunofluorescence. Data are re-
presentative of two independent experi-
ments for each time point.
(A) 24 hr after TRITC painting, substantial
numbers of dermal-derived DCs are already
found in the outer paracortex, in contiguity
with the B cell follicles (b), whereas the rare
LC-derived DCs present at that time point
are already found intermingled with steady-
state, LC-derived cells. 1303 × 1303 m
field.
(B) Enlarged section of an auricular LN re-
moved 24 hr after TRITC painting and
stained with CD3 (blue). Some TRITC+ der-
mal-derived DCs (arrow) and steady-state,
migrating LC-derived DCs can be identified
in the subscapsular and trabecular sinuses.
Rare TRITC+ LC-derived DCs, possibly in
transit to the inner paracortex are also
found. The area in contiguity with the B cell
follicles (b) is primarily composed of dermal-
derived DCs. 503 × 503 m field.
(C) Consistent with the results shown in Fig-
ure 3C, 72 hr after TRITC painting, the num-
ber of incoming LC-derived DCs (yellow) ap-
proaches that of incoming dermal DCs (red).
Dermal-derived DCs occupy the outer para-
cortex, in contiguity to B cell-rich follicles
stained with B220 (blue). 1303 × 1303 m
field.
(D) Section of an auricular LN removed 96 hr after TRITC painting and stained for HEVs (blue). 783 × 783 m field.
(E) Enlarged sections of an auricular LN 72 hr after TRITC painting. Incoming LC-derived DCs (yellow) are evenly admixed with steady-state
LC-derived DCs (green) in the inner paracortex. 1066 × 504 m field.with recent data obtained on bulk, tissue-derived DCs
(Itano et al., 2003; Wilson et al., 2003), incoming LCs
found in draining CLNs after TRITC painting did not ex-
hibit a more mature surface phenotype than that of LCs
reaching CLNs under noninflammatory conditions.
Dermal- and Langerhans-Derived DCs Colonize
Distinct LN Areas
Confocal microscopy analysis of CLN sections from
Lang-EGFP mice obtained 3 days after TRITC epicuta-
neous application showed numerous TRITC+ cells with
a stellate morphology (Figures 4C and 4E), a result con-
sistent with the kinetics of migration of TRITC-laden
DCs to draining LNs determined by FACS analysis (Fig-
ure 3C). On CLN sections, LCs that had reached the
draining auricular LNs prior to TRITC application arecolored in green. Incoming EGFP+ LC-derived DCs
(green) that had captured TRITC (red) in the epidermis
had yellow-colored cell bodies, whereas EGFP− der-
mal-derived DCs that had captured TRITC in the dermis
appeared as red cells (Figures 3B and 4). Staining with
the anti-mouse DC Ab MCA948 (Breel et al., 1987) con-
firmed that both the yellow and green cells were bona
fide DCs (data not shown). Staining for HEVs further
showed that neither LC-derived nor dermal-derived
TRITC+ DCs localized preferentially in contiguity to
HEVs (Figures 4D and 4E).
Unexpectedly, 3 days after TRITC application, TRITC-
laden dermal DCs and TRITC-laden LCs occupied dis-
tinct, contiguous locations within the paracortical, T
cell-rich zone (Figures 4C and 4E). TRITC-laden dermal
DCs migrated into the outer paracortex, just beneath
the B cell follicles, whereas TRITC-laden LCs migrated
Immunity
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iwere evenly intermingled with the EGFP+ LCs present
in the draining auricular LN prior to skin painting. Im- i
dportantly, this segregated distribution (TRITC+ and
TRITC− LC-derived DCs versus TRITC+ dermal-derived a
tDCs) held true at all the time points examined after epi-
cutaneous sensitization (Figure 4). As shown in Figures C
DS4A and S4B, even in steady-state CLNs, LC-derived
DCs did not distribute evenly within the paracortex: o
mthey systematically occupied a “deeper” position be-
neath an outer ring that likely contains dermal-derived t
iDCs and in most instances separates them from the B
cell follicles. Therefore, the possibility to discriminate D
tLC-derived DCs from dermal-derived DCs demon-
strated that these two DC subsets migrate to distinct d
zareas of the paracortex of draining CLNs.
LIn Vivo Ablation of Langerin+ DCs
CWe used a DT-based strategy (Jung et al., 2002) to in-
tduce systemic elimination of langerin+ cells in vivo.
iEGFP-expressing LCs showed more intense EGFP fluo-
drescence than those expressing DTREGFP (Figure 1B).
2As a single copy of the Lang-DTREGFP allele was suffi-
ucient to render LCs sensitive to DT (data not shown),
pwe systematically used Lang-EGFP/Lang-DTREGFP
bheterozygous mice to facilitate depletion monitoring. A
Dsingle intraperitoneal injection of 100 ng of DT elimi-
Lnated most of the LCs found in the epidermis as de-
ttected by immunofluorescence of epidermal sheets
a(Figure 5A). A complete LC depletion was already mani-
tfest 24 hr after treatment and persisted for 6–7 days.
LLCs were then slowly restored; 14 days after DT treat-
(ment, scarce patches of LCs were found (Figure 5A),
5and LCs only reached a normal density w6 weeks after
nDT treatment. Before reaching a normal density, epider-
1mal LCs showed dendrites that were more scattered
tthan steady-state epidermal LCs (Figure 5A, compare
tpanels before and 14 days after DT treatment). The
icomplete ablation of LCs had no measurable effect on
mthe morphology of keratinocytes (Figure S2E and S2F)
Lor on the density and morphology of the DETCs (Figure
w5A). Moreover, analysis of hematoxylin and eosin-
tstained skin sections showed that DT treatment did not
atrigger detectable sign of inflammation (Figure S2). Im-
tportantly, DT treatment did not affect dermal DCs as
sdocumented by analysis of the CD11c+ DCs that mi-
tgrate out of DT-treated ear skin explants cultured in
Tmedium containing CCL21 (Figure 5B).
hTo assess whether the two langerin+ DC subsets (LC-
mderived DCs and CD8α+ DCs) identified in CLNs
were also sensitive to DT treatment, Lang-EGFP/Lang-
DTREGFP mice were injected with 1 g of DT, and the D
presence of EGFP+ DCs in CLNs was analyzed at dif-
ferent time points after injection (Figures 5C and 5D). A
EConsidering that the dose of DT (100 ng) used to elimi-
nate skin LCs had only a partial effect on LC-derived m
mDCs and CD8α+ DCs present in Lang-EGFP/Lang-
DTREGFP CLNs, we used 1 g DT, because it did not t
dresult in detectable systemic toxicity. DT injection led to
rapid depletion of both langerin+ DCs subsets, whereas T
mlangerin− CD11c+ DCs remained unaffected (Figure 5C).
DT-induced depletion of the two langerin+ DC subsets C
apersisted for 4–5 days, after which both subsets wereradually restored. In contrast to the situation observed
n the skin where a complete LC ablation was reached,
n CLNs, we only achieved 93% and 70% maximum re-
uction in the absolute numbers of LC-derived DCs
nd CD8α+ DCs, respectively (Figure 5D). This magni-
ude of depletion is similar to that reported in LNs of
D11c-DTR transgenic mice that had received a single
T injection (Jung et al., 2002). A second administration
f DT, 2–3 days after the first one did not enhance the
agnitude of depletion shown in Figure 5D. Therefore,
he complete ablation of skin-resident LCs by admin-
stration of DT into heterozygous LangEGFP/Lang-
TR-EGFP mice provided us with a window of 6–7 days
o investigate the relative contribution of LCs and of
ermal DCs to the T cell activation after skin immuni-
ation.
Cs Are Dispensable for CHS
HS is a skin inflammatory reaction to topical applica-
ion of haptens such as dinitrofluorobenzene (DNFB). It
s mediated by CD8+ T cells primed in CLN by poorly
efined, skin-derived Ag-presenting cells (Akiba et al.,
002; Kehren et al., 1999). Because LCs could contrib-
te both to the induction phase and to the elicitation
hase of CHS, DT-induced LC depletion was achieved
efore sensitization and/or prior to ear challenge with
NFB. To ensure a complete depletion of epidermal
Cs, LangEGFP/Lang-DTR-EGFP mice received one in-
raperitoneal injection of DT 3 days before sensitization
nd one subcutaneous injection of DT 1 day after sensi-
ization. This regimen led to the complete depletion of
Cs from the skin up to 7 days after the last treatment
data not shown). When mice were challenged on day
, the absence of LC at the time of sensitization did
ot affect induction of CHS to DNFB, which peaked
–2 days after challenge and progressively resolved
hereafter, as in DT-untreated controls (Figure 6A). To
est whether the absence of LCs might affect the skin
nflammatory response induced by DNFB-specific
emory T cells, DNFB-sensitized and DT-untreated
angEGFP/Lang-DTREGFP mice were rested for 6
eeks and then depleted of epidermal LCs by DT injec-
ion 3 days before hapten challenge. The lack of LCs
ffected neither the intensity nor the duration of hap-
en-specific skin inflammation, demonstrating that
kin-resident LCs are also dispensable for the elicita-
ion phase of CHS during recall responses (Figure 6B).
herefore, LCs are neither required for priming of naive
apten-specific T cells in CLNs nor for activation of
emory effector T cells in the skin.
iscussion
knockin approach allowed us to specifically express
GFP in LCs. Although, the level of EGFP fluorescence
anifested by LCs allowed us to use intravital confocal
icroscopy to visualize their behavior in the epidermis,
hey were insufficient to permit their visualization in the
eep paracortex of CLNs by two-photon microscopy.
he cellular environment provided to LCs by the epider-
is is distinct from the one they encounter later in
LNs. Resting epidermal LCs are intermingled with ker-
tinocytes and establish tight contacts with them via
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651Figure 5. DT Sensitivity of the Two Langerin+
DC Subsets Found in Lang-EGFP/Lang-
DTREGFP Mice
(A) Confocal microscopic analysis of epider-
mal sheets from Lang-EGFP/Lang-DTREGFP
mice was carried out 24 hr, 48 hr, 6 days, and
14 days after i.p. injection of 100 ng of DT.
The presence of LCs (EGFP+, green) was
crosschecked by staining with an anti-lang-
erin Ab (langerin, red). The last row shows
that CD3+ DETCs are not affected by DT-
treatment. Epidermal sheets of Lang-EGFP/
Lang-DTREGFP mice before DT injection are
also shown for comparison. Panels in the
last column show that DT injection had no
effect on the LCs and DETCs found in the
epidermis of wt mice. Volume section:
206.8 × 206.8 × 10.4 m (fields showed at 24
hr, 48 hr, and 6 days after DT treatment) and
325.8 × 325.8 × 12.4 m (fields shown be-
fore DT treatment and 14 days after DT
treatment).
(B) Ear explants were prepared from Lang-
EGFP/Lang-DTREGFP mice that were left
untreated or had received 1 g of DT i.p. 4
days prior to analysis and cultured in the
presence of CCL21. The CD11c+ cells mi-
grating out of the ear explants were analyzed
by using CD205 versus EGFP dot plots. The
percentages of LC-derived DCs (CD205+,
EGFP+) and of dermal-derived DCs (CD205+,
EGFP−) among CD11c+ DCs are shown. Also
shown is the total number of dermal-derived
(DEC205+, EGFP−) DCs and of LC-derived
(DEC205+, EGFP+) DCs that migrated out of
ear skin in the case of untreated and of DT-
treated Lang-EGFP/Lang-DTREGFP mice.
Data represent mean ± SD of two indepen-
dent experiments.
(C and D) Kinetics of disappearance and of
reappearance of the EGFP+, CD8α− and
EGFP+, CD8α+ DC subsets found in Lang-
EGFP/Lang-DTREGFP CLNs after injection
of 1 g of DT. FACS analysis of DC subsets
isolated from all skin-draining lymph nodes
was carried out prior to (day 0), and 1, 2, 3,
4, 7, and 14 days after DT injection. The ab-
solute number of CD11c+ DCs; CD11c+,
EGFP+ DCs; LC-derived (CD11c+, EGFP+,
CD8α−) DCs; and blood-derived CD8α+
(CD11c+, EGFP+, CD8α+) DCs per CLN are
shown. Data represent mean ± SD of at least
two mice per time point and correspond to
three independent experiments.E-cadherin-mediated adhesion. Interestingly, upon ac-
tivation, LCs adopt a behavior reminiscent of trans-
formed epithelial cells, lose their contacts with the
neighboring keratinocytes, become mobile, and cross
epidermal basement membranes to reach the dermis
(Ratzinger et al., 2002; Stoitzner et al., 2002). We
showed that most LCs were sessile under steady-state
conditions and started to become motile w16 hr after
mechanical stress of the skin. Whereas occasional LC
body motion occurred under steady-state conditions,
disruption of the stratum corneum mobilized all the
LCs. LC displacements spanned 20–50 microns over 60
min, a value comparable to that observed for DCs pre-
sent within secondary lymphoid organs (Lindquist et
al., 2004).Because most epidermal LCs needed over 16 hr to
experience extensive dendrite sprouting and retraction,
this motility is likely secondary to the production of in-
flammatory mediators by mechanically stressed kerati-
nocytes. Consistent with this view, tape stripping
induces the production of IL-1β and TNF-α by keratino-
cytes (Nickoloff and Naidu, 1994), and LCs are known
to migrate in response to these inflammatory cytokines.
After TRITC painting, dermal DCs reached draining
CLNs before LCs. It probably takes a longer time for
LCs to reach the CLNs because they additionally need
to detach from neighboring keratinocytes. In previous
studies, the function of DCs migrating to draining LNs
has been checked 2 days after sensitization (Allan et
al., 2003; Itano et al., 2003). Considering that the bulk of
Immunity
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Figure 6. Epidermal LCs Are Dispensable for CHS
(A) 3 days before and 1 day after DNFB sensitization, Lang-EGFP/
Lang-DTREGFP heterozygous mice were injected with 1 g DT C
(closed symbols) or with PBS (open symbols). 5 days later, both p
groups of mice were challenged by application of DNFB on the ear,
Dand CHS was determined by ear swelling (m) at various times
aafter challenge. The enhanced response observed 24 hr after DNFB
echallenge in DT-treated Lang-EGFP/Lang-DTREGFP mice (marked
with an asterisk) was not found statistically significant by using a m
Mann-Whitney-Wilcoxon ranking test. Data represent ± SD of two E
experiments with three mice per group. f
(B) Sensitized mice were rested for 6 weeks and then treated with
CDT (closed symbols) or PBS (open symbols) 3 days before chal-
mlenging them with a second application of DNFB on the ear. CHS
dwas determined as above. Data ± SD are representative of two
experiments with five mice per group. n
D
bimmigrating LCs lags behind that of immigrating dermal
fDCs and peaked only at day 4 after skin sensitization,
hour results indicate that these studies primarily probed
the function of incoming dermal-derived DCs rather
sthan that of LC-derived DCs.
mUnder steady-state conditions, LC-derived DCs within
2CLNs are continuously replaced by emigrants from the
dskin (Kamath et al., 2002). Consistent with this observa-
ation, vital confocal imaging of steady-state epidermis
m
showed a few motile LCs likely visualized in the pro-
d
cess of initiating migration. Under noninflammatory
w
conditions, LCs carry skin-specific components to
n
draining CLNs (Hemmi et al., 2001). It has been hypoth- r
esized that migrating, steady-state LCs do not express s
maximal levels of MHCII and costimulatory molecules d
and that this might prevent immunization against epi- t
dermal self-determinants (Steinman and Nussenzweig, C
2002). However, in steady-state CLNs of Lang-EGFP c
mice, LC-derived DCs expressed surface levels of co- L
stimulatory molecules (MHCII, CD86, and CD40) similar p
to those found on LCs reaching CLNs under an inflam- t
matory setting. The recent data of Sporri and Reis t
(2005) allow us to understand this paradoxical finding. o
Indirect activation of DCs by inflammatory signals pro- g
duced in trans by neighboring cells, for instance by me- a
chanically stressed keratinocytes, leads to upregulation n
of MHCII and costimulatory molecules. However, in a
contrast to DCs stimulated in cis via Toll-like receptors, d
trans-activated DCs lack the ability to produce IL-12 D
and to drive differentiation of CD4 T cells into effectors o
(Sporri and Reis, 2005). Therefore, a mature DC pheno- c
type, as defined by high expression of MHCII and of p
costimulatory molecules, does not necessarily equate r
a state of functional maturity, as defined by the ability s
of inducing effector T cells. Whether the mature cell n
surface phenotype reached by mouse LCs reaching C
CCLNs under steady-state conditions is associated withhe production of IL-12 and reflects the existence of
ubclinical microbial infections remains to be deter-
ined. However, steady-state, skin-derived DCs that
each CLNs of mice kept under germ-free conditions
lso expressed a mature cell surface phenotype (Heath
nd Villadangos, 2005). Therefore, the sterile trigger
hat results in the steady-state migration of LCs re-
ains to be determined.
In previous studies, langerin transcripts were de-
ected in spleen and in non-CLNs. Among the latter,
LNs do not drain any skin territory and are primarily
he destination of DCs that originate from the lamina
ropria and the Peyer’s patches of the small intestine.
onsidering that the gut mucosa and the Peyer’s
atches of Lang-EGFP mice lack detectable EGFP+
Cs (data not shown), it was surprising to find in MLNs
population of langerin+ DCs. Although the spleen
ssentially traps blood-derived cells, it also contains a
inor population of langerin+ DCs. By using Lang-
GFP knockin mice, we showed that the EGFP+ DCs
ound in MLNs and spleen belong to the blood-derived
D8α+ subset. Based on our data, three points can be
ade. One, langerin is expressed by both tissue-
erived and blood-derived DCs. Two, langerin alone is
ot a reliable marker to specifically identify LC-derived
Cs outside the skin; most CD8α+ DCs express it, al-
eit at lower levels than LCs. Three, DCs differentiating
rom blood precursors can express langerin without
aving previously resided within epithelia.
Considering that the LC-derived DCs present in
teady-state CLNs are expected to derive from epider-
al LCs and to be nondividing end cells (Kamath et al.,
002), the replacement kinetics of LC-derived DCs that
ied in CLNs upon DT treatment should have showed
lag relative to that of LCs that died in the epider-
is. Unexpectedly, after DT-induced ablation, the LC-
erived DC subset found in CLNs was reconstituted
ith a faster kinetics than that of epidermal LCs. We do
ot have an explanation for this observation yet, and it
emains possible that the w103 LC-derived DCs that
urvived DT treatment in a given CLN and/or blood-
erived DC precursors also contributed to the reconsti-
ution of the pool of langerin+, CD8α− DCs found in
LNs. Regardless of the mechanism leading to the re-
onstitution of this CLN pool, administration of DT to
angEGFP/Lang-DTR-EGFP mice resulted in the com-
lete ablation of skin-resident LCs. This complete abla-
ion persisted for 6–7 days, providing us with ample
ime to investigate the relative contribution of LCs and
f dermal DCs to CHS. Although indirect evidence sug-
ested that LCs play a critical role in CHS (Sullivan et
l., 1986), other studies proposed that LCs might be
ecessary, but not sufficient, to trigger CHS (Bacci et
l., 1997). We showed that conditional ablation of LCs
oes not affect the intensity and kinetics of CHS to
NFB and that LCs are dispensable both for induction
f T cell priming in draining LNs and for activation of spe-
ific effector T cells in skin upon Ag challenge. It is thus
ossible that the hapten-laden dermal DCs that start
eaching draining CLNs 24 hr after skin sensitization con-
titute the Ag-presenting cells responsible for CHS. Alter-
atively, minute amounts of DNFB may reach draining
LNs via the lymph, allowing DCs already present in
LNs to acquire DNFB and prime specific CD8+ T cells.
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DCs and TRITC-laden, LC-derived DCs were not evenly
intermingled in the paracortex of draining CLNs. They
occupied distinct, contiguous areas within this T cell-
rich zone, and this segregation occurred at all time-
points analyzed after epicutaneous TRITC painting.
This segregated distribution likely extends to steady-
state CLNs and points to the existence of a previously
unrecognized microanatomy of the paracortex of CLNs.
In a manner similar to T and B cells, the cues that con-
fine the movement of incoming LC-derived DCs and
dermal-derived DCs to their respective areas likely rely
on the expression of distinct chemokine or lipid media-
tor receptors. Whether these distinct locations confer
to LC-derived DCs and dermal-derived DCs the ability
to encounter distinct T cell subsets remains to be
established.
In summary, our results provided a dynamic view of
LCs within the epidermis under steady-state and in-
flammatory conditions. We also showed that dermal
DCs arrived in CLNs first and colonized areas distinct
from slower migrating LCs. This work also raises ques-
tions on the role played by the two langerin+ DC sub-
sets identified in the thymus. Moreover, the possibility
to conditionally eliminate LCs in vivo should clarify their
role in inflammatory skin disorders and in the many
transcutaneous immunization attempts aiming at in-
ducing robust immunity against cancer or virus-associ-
ated diseases.
Experimental Procedures
Mice
Mice were housed under specific pathogen-free conditions and
handled in accordance with French and European directives.
DC Isolation
DCs were isolated as previously described (Vremec et al., 2000).
DC Migration from Cultured Ear Skin Explants
DCs that had migrated from ear skin explants were prepared as
previously described (Henri et al., 2001).
Fluorescent Labeling of DCs in Ear Skin
Tetramethylrhodamine-5-(and-6)-isothiocyanate (TRITC) from Mo-
lecular Probes was prepared in DMSO and then diluted to 1% in a
1 to 1 acetone-dibutylphtalate mix. 10 l of this 10 mg/ml TRITC
solution was used to paint the dorsal side of both ears.
Antibodies
CD11c-APC (HL3), CD8α-PerCPCy5.5 (53-6.7), CD8α-PE Cy7 (53-
6.7), CD40-PE (HM40-3), MHC II-PE (Aβb, AF6-120.1), and biotiny-
lated CD80 (1610A1), CD86 (GL1), MHC II Ab were all from BD Phar-
mingen, except Ab CD205 (CL89145) that was purchased from
Cedarlane. Anti-langerin Ab 929F3 was used for intracytoplasmic
staining (Kissenpfennig et al., 2005). The anti-mouse DC Ab
MCA948 was from Serotec. Streptavidin-conjugated APC-Cy7 (Cal-
tag) and goat anti-rat Ig-specific polyclonal Ab-PE (Pharmingen)
were used as secondary-step reagents.
Flow Cytometry
Before staining, cells were preincubated on ice for at least 10 min
with polyclonal mouse and rat Ig to block Fc receptors. Five-color
multiparameter FACS analysis was performed by using an LSR sys-
tem (BD). Unless stated otherwise, autofluorescent cells were
gated out by using the FL3 channel, and the EGFP+ cells scoring
in the FL1 channel were stained with Ab coupled with PE (FL2),APC (FL4), APC-Cy7 (FL5), and PE-Cy7 (FL6). FACS data were ana-
lyzed by using FlowJo version 4.6.2 (Treestar).
In Vivo Depletion of Langerin+ DCs
For systemic in vivo depletion of langerin+ DCs, Lang-EGFP/Lang-
DTREGFP mice were injected i.p. with 100 ng DT (List Biological
Laboratories) for LC ablation in the epidermis or with 1 g DT for
ablation of langerin-expressing cells found in subcutaneous-drain-
ing LNs.
CHS
CHS to DNFB was determined by the mouse ear-swelling test as
previously described (Kehren et al., 1999). Ear thickness was mea-
sured by a blinded observer using a caliper. Ear swelling in unsensi-
tized but ear-challenged mice was usually <10 m.
Supplemental Data
Supplemental Data include Supplemental Experimental Pro-
cedures, Supplemental References, seven figures, and 12 movies
and are available with this article online at http://www.immunity.
com/cgi/content/full/22/5/643/DC1/.
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